Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing)

Manufactured by Sansure Biotech Inc., China - www.sansure.com.cn/ 

Related Scientific Literature

• Comparative performance of four nucleic acid amplification tests for SARS-CoV-2 virus
• Saliva Sample as a Non-Invasive Specimen for the Diagnosis of Coronavirus Disease-2019 (COVID-19): a Cross-Sectional Study
• Performance & Quality Evaluation of Marketed COVID-19 RNA Detection Kits
• An acceptable method to evaluate the analytical performance of real-time fluorescent RT-PCR targeting SARS-CoV-2
• Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases
• Current and Perspective Diagnostic Techniques for COVID-19
• Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
• Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2
• Influence of Storage Conditions on SARS-CoV-2 Nucleic Acid Detection in Throat Swabs
• Development of an automatic integrated gene detection system for novel severe acute respiratory syndrome-related coronavirus (SARS-CoV2)
• Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2
• Assay Techniques and Test Development for COVID-19 Diagnosis.
• Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study
• Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements